David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
PUT
Verizon
VZ
$207B
| $19M | 0.03% |
351,100
-710,800
| -67% | -$35.6M |
|
552
Check Point Software Technologies
CHKP
$13.3B
| $18.9M | 0.03% |
216,565
-285,823
| -57% | -$23M |
|
|
TCO
553
DELISTED
Taubman Centers Inc.
TCO
| $18.9M | 0.03% |
265,684
+224,730
| +549% | +$15.9M |
|
554
PUT
Western Digital
WDC
$153B
| $18.9M | 0.03% |
529,068
+24,079
| +5% | +$861K |
|
555
PUT
Whirlpool
WHR
$2.61B
| $18.9M | 0.03% |
104,700
-100,100
| -49% | -$14.9M |
|
556
BioMarin Pharmaceuticals
BMRN
$12.7B
| $18.8M | 0.03% |
228,272
-169,822
| -43% | -$13.8M |
|
557
GSK
GSK
$104B
| $18.8M | 0.03% |
+370,460
| New | +$18.5M |
|
558
First Horizon
FHN
$11.7B
| $18.7M | 0.03% |
1,425,852
+462,182
| +48% | +$5.89M |
|
559
Reliance Steel & Aluminium
RS
$19.9B
| $18.6M | 0.03% |
268,927
-25,061
| -9% | -$1.52M |
|
560
Nucor
NUE
$56.7B
| $18.5M | 0.03% |
390,965
+291,537
| +293% | +$11.9M |
|
561
Consolidated Edison
ED
$39.4B
| $18.5M | 0.03% |
240,980
+218,821
| +988% | +$15.5M |
|
562
Universal Health Services
UHS
$10.5B
| $18.5M | 0.03% |
147,972
+45,535
| +44% | +$5.12M |
|
563
PUT
Lockheed Martin
LMT
$129B
| $18.4M | 0.03% |
83,100
-345,700
| -81% | -$74.4M |
|
564
Constellium
CSTM
$3.65B
| $18.4M | 0.03% |
3,542,183
+1,215,245
| +52% | +$6.99M |
|
|
RAX
565
DELISTED
Rackspace Hosting Inc
RAX
| $18.4M | 0.03% |
850,670
+312,295
| +58% | +$6.37M |
|
566
Olin
OLN
$2.07B
| $18.3M | 0.03% |
1,054,326
+101,700
| +11% | +$1.57M |
|
|
UTEK
567
DELISTED
Ultratech Inc.
UTEK
| $18.3M | 0.03% |
837,579
+41,686
| +5% | +$823K |
|
|
QIHU
568
CALL
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $18.3M | 0.03% |
241,900
-50,000
| -17% | -$3.61M |
|
569
Cameco
CCJ
$44.7B
| $18.2M | 0.03% |
1,420,874
+49,311
| +4% | +$590K |
|
|
WPX
570
DELISTED
WPX Energy, Inc.
WPX
| $18.2M | 0.03% |
2,597,609
-947,133
| -27% | -$4.83M |
|
571
PUT
ConocoPhillips
COP
$162B
| $18.1M | 0.03% |
448,800
-444,700
| -50% | -$16.9M |
|
572
PUT
General Motors
GM
$76.2B
| $18.1M | 0.03% |
574,400
-1,012,900
| -64% | -$30.5M |
|
573
CALL
Valero Energy
VLO
$100B
| $18M | 0.03% |
280,900
-192,900
| -41% | -$12.3M |
|
574
PPG Industries
PPG
$25.4B
| $18M | 0.03% |
161,507
-119,448
| -43% | -$11.7M |
|
|
CXP
575
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $18M | 0.03% |
817,839
+85,661
| +12% | +$1.85M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.